{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:31Z","timestamp":1793224411776,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031644","name":"Zambon Italia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jhepr.2022.100460","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T19:03:30Z","timestamp":1645556610000},"page":"100460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-6164","authenticated-orcid":false,"given":"Maaike","family":"Biewenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-188X","authenticated-orcid":false,"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Vergunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J.M.","family":"Marijnissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek A.","family":"van der Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan J.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-2290","authenticated-orcid":false,"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6527-764X","authenticated-orcid":false,"given":"Bart","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100460_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100460_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/liv.14082","article-title":"Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country","volume":"39","author":"Choi","year":"2019","journal-title":"Liver Int"},{"issue":"Suppl. 2","key":"10.1016\/j.jhepr.2022.100460_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap syndromes","volume":"33","author":"Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2022.100460_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.jhepr.2022.100460_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2022.100460_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/sji.12339","article-title":"CD21(-\/low) B cells: a snapshot of a unique B cell subset in health and disease","volume":"82","author":"Thorarinsdottir","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib8","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.humimm.2007.03.010","article-title":"Elevated serum BAFF levels in patients with autoimmune hepatitis","volume":"68","author":"Migita","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s40064-016-2512-y","article-title":"Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis","volume":"5","author":"Abe","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.jhepr.2022.100460_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/liv.12245","article-title":"Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis","volume":"34","author":"Ma","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100460_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100460_bib14","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","article-title":"Bm1\u2013Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sj\u00f6gren's syndrome","volume":"167","author":"Bohnhorst","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003194","article-title":"B-cell activating factor belonging to the tumor necrosis factor family and interferon-gamma-inducible protein-10 in autoimmune hepatitis","volume":"95","author":"Nishikawa","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2022.100460_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","article-title":"T\u00a0follicular helper cells in autoimmune disorders","volume":"9","author":"Gensous","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of IL-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jhepr.2022.100460_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100460_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100460_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cgh.2008.08.018","article-title":"Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome","volume":"6","author":"Al-Chalabi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100460_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.11.013","article-title":"Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months","volume":"18","author":"Pape","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100460_bib22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new\u00a0risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2022.100460_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000321619","article-title":"Analysis of IL2\/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis","volume":"84","author":"Stallhofer","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jhepr.2022.100460_bib24","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100460_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep4.1202","article-title":"Immune alterations in patients with type 1 autoimmune hepatitis persist upon standard immunosuppressive treatment","volume":"2","author":"Renand","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100460_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fimmu.2019.00318","article-title":"B\u00a0cell dysfunction associated with aging and autoimmune diseases","volume":"10","author":"Ma","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2022.100460_bib27","doi-asserted-by":"crossref","first-page":"100094","DOI":"10.1016\/j.jhepr.2020.100094","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2022.100460_bib28","doi-asserted-by":"crossref","first-page":"102534","DOI":"10.1016\/j.autrev.2020.102534","article-title":"The role of complement activation in autoimmune liver disease","volume":"19","author":"Biewenga","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhepr.2022.100460_bib29","doi-asserted-by":"crossref","first-page":"100123","DOI":"10.1016\/j.jhepr.2020.100123","article-title":"Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis","volume":"2","author":"Arvaniti","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2022.100460_bib30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1016\/j.jhepr.2025.101447","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:09:23Z","timestamp":1762632563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2589555922000325"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100460","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100460"}}